免疫疗法
放射治疗
医学
肺癌
肿瘤科
癌症
临床试验
内科学
作者
Hui Wang,Zhuoran Yao,Kai Kang,Lin Zhou,Weigang Xiu,Jianguo Sun,Conghua Xie,Min Yu,Yanying Li,Yan Zhang,Yue Zheng,Guo Lin,Xiangyu Pan,Yijun Wu,Ren Luo,Laduona Wang,Min Tang,Shuangsi Liao,Jiang Zhu,Xiaojuan Zhou
出处
期刊:Med
[Elsevier BV]
日期:2024-07-03
卷期号:5 (10): 1237-1254.e9
被引量:6
标识
DOI:10.1016/j.medj.2024.06.002
摘要
Immune checkpoint inhibitors (ICIs) provide modest but unsatisfactory benefits for extensive-stage small cell lung cancer (ES-SCLC). Developing strategies for treating ES-SCLC is critical.
科研通智能强力驱动
Strongly Powered by AbleSci AI